DUBLIN–(BUSINESS WIRE)–The “Cancer Cachexia: Drug Development Pipeline Study, H1 2018” report has been added to ResearchAndMarkets.com’s offering. Cancer Cachexia pipeline comprises of 17 drugs under development as of March 2018. Of these, 1 drug is in Phase 1 and 4 … Continue reading
Cet article Cancer Cachexia Drug Development Pipeline Study, H1 2018 – ResearchAndMarkets.com est apparu en premier sur Biotech 365.